Revvity Inc (BSP:R1VT34)
R$ 18.52 0 (0%) Market Cap: 63.99 Bil Enterprise Value: 75.91 Bil PE Ratio: 93.84 PB Ratio: 1.78 GF Score: 84/100

PerkinElmer Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2020 / 01:00PM GMT
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Good morning, everyone. Welcome to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard, senior life science tools and diagnostics analyst here at the firm. Very happy to have PerkinElmer joining us in this virtual setting again this year. And on behalf of the company, CFO, Mr. Jamey Mock; also on the line, Head of IR, Bryan Kipp. Jamey, Bryan, thanks for being here.

James M. Mock
PerkinElmer, Inc. - Senior VP & CFO

Thanks for having us, Brandon.

Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Maybe just to kick off, Jamey, on the topic and focus, just to start off at a high level. Clearly, very fluid situation as it relates to COVID-19, but curious if you could just set the table for us and provide a bit of a brief state of the union of where you guys are today in terms of the various offerings that PerkinElmer is sort of bringing to bear sort of between real-time PCR, antibody testing, and where

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot